Predicting disease progression in high-grade glioma with neuropsychological parameters: the value of personalized longitudinal assessment

PURPOSE: Progressive disease in patients with high-grade glioma may be reflected in cognitive decline. However, the cognitive functions most sensitive to progression may differ between patients. We investigated whether decline on a personalized selection of tests predicted progressive disease accord...

Descripción completa

Detalles Bibliográficos
Autores principales: Butterbrod, Elke, Bruijn, Jimme, Braaksma, Meriam M., Rutten, Geert-Jan M., Tijssen, Cees C., Hanse, Monique C. J., Sitskoorn, Margriet M., Gehring, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764928/
https://www.ncbi.nlm.nih.gov/pubmed/31342318
http://dx.doi.org/10.1007/s11060-019-03249-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764928/
https://www.ncbi.nlm.nih.gov/pubmed/31342318
http://dx.doi.org/10.1007/s11060-019-03249-1

Ejemplares similares